This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Pacira Pharmaceuticals, Inc.. Active years: 2017-2018.
Company Filing History:
Years Active: 2017-2018
Title: Innovations by Benjamin W. Li in Drug Formulation
Introduction
Benjamin W. Li is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of drug formulation, particularly in the development of sustained release formulations for methotrexate. His work has implications for treating autoimmune diseases and cancer.
Latest Patents
Benjamin W. Li holds 2 patents. His latest patents include a sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent. These formulations comprise a multivesicular liposome and methotrexate (MTX), which allows for a controlled release of MTX between 5% and 50% of the concentration of an immediate release dosage form. The duration of this release lasts from about 1 to about 30 days. Additionally, methods of treating autoimmune diseases and cancer by administering these formulations of MTX are disclosed in his patents.
Career Highlights
Benjamin W. Li is currently associated with Pacira Pharmaceuticals, Inc. His work at the company focuses on innovative drug delivery systems that enhance the efficacy of existing treatments.
Collaborations
He has collaborated with notable coworkers such as Lois Gibson and Liangjin Zhu, contributing to advancements in pharmaceutical formulations.
Conclusion
Benjamin W. Li's innovative work in drug formulation, particularly with methotrexate, showcases his commitment to improving treatment options for patients with autoimmune diseases and cancer. His contributions are paving the way for more effective therapies in the pharmaceutical industry.